The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

Bread and rolls sold in six states have been recalled over 'glass fragments,' according to the U.S. Food and Drug ...

OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...

A Blue Cross Blue Shield policy will force some patients to self-inject medicine, with potentially dangerous results.

Urcosimod phase 2 trial treating Neuropathic Corneal Pain ("NCP”) patients was initiated in October 2024 and designed as a ...

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

How have the wild initial months of Donald Trump’s return to the White House landed on Washington? We asked the people who ...

WHETHER we need a 3pm pick-me-up or we’re gearing up for a tough workout, many of us reach for an energy drink.  But before ...

Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from ...

Bristol-Myers Squibb finally has FDA approval for its CAR-T therapy liso-cel, which has been cleared by the US regulator as Breyanzi for certain forms of large B-cell lymphoma. The green light ...

Madison, a twelve-year-old from Illinois, visits a medical clinic every other week to get injections of Xolair, a powerful ...